-
The_genomic_architecture_of_mesothelioma_
Study
EGAS00001000353
-
Balanced_Brain_Tumour_Whole_Genome_Sequencing
Study
EGAS00001000360
-
Ewings_Sarcoma_Rearrangement_Screen
Study
EGAS00001000362
-
Angiosarcoma_follow_up_study
Study
EGAS00001000405
-
Targeted_gene_fusion_sequencing__Fus_seq__in_mesothelioma
Study
EGAS00001000390
-
Characterization_of_individual_foci_of_multicentric_multifocal_breast_cancer_using_targeted_next_generation_sequencing
Study
EGAS00001000407
-
Association of Age at Diagnosis and Genetic Mutations in Patients with Neuroblastoma
Study
EGAS00001000213
-
Exome-sequencing identifies new oncogenes and tumor suppressor genes recurrently altered in hepatocellular carcinoma
Study
EGAS00001000217
-
Whole-genome-Sequencing of adult medulloblastoma
Study
EGAS00001000393
-
Ewings_Sarcoma_RNA_seq_drug_sensitivity
Study
EGAS00001000419
-
Exome_sequencing_of_patients_with_Ewings_sarcoma_
Study
EGAS00001000266
-
Genetic landscape of pediatric Medulloblastoma
Study
EGAS00001000347
-
Discovery_of_resistance_mechanisms_to_the_BRAF_inhibitor_vemurafenib_in_metastatic_BRAF_mutant_melanoma
Study
EGAS00001000551
-
CMF_RNA_sequencing
Study
EGAS00001000470
-
Whole genome sequencing of chondrosarcoma
Study
EGAS00001000505
-
Angiosarcoma_whole_exome
Study
EGAS00001000588
-
Angiosarcoma_targeted_pulldown_cancer_gene_panel
Study
EGAS00001000589
-
Angiosarcoma_RNA_sequencing
Study
EGAS00001000590
-
Chordoma_Sequencing_Project_Whole_Genome
Study
EGAS00001000409
-
Chordoma_Sequencing_Project_RNAseq
Study
EGAS00001000410
-
The_Transcriptome_of_PLX4032_resistance
Study
EGAS00001000413
-
Analysis_of_resistance_to_PLX4032
Study
EGAS00001000415
-
WTCCC2 project Glaucoma (GL) samples
Study
EGAS00001000624
-
Leiden_melanomafamilies
Study
EGAS00001000627
-
Mutational_Signatures_of_relapse_in_rectal_cancer_FFPE_samples_in_the_CR07_clinical_trial
Study
EGAS00001000651
-
Whole genome and transcriptome analysis of a sporadic and recurring parathyroid carcinoma
Study
EGAS00001000484
-
Integrative genomic profiling of hepatocellular adenomas reveals recurrent FRK activating mutations and mutational processes of malignant transformation
Study
EGAS00001000679
-
BRAF_and_MEK_resistant_cell_line_clones
Study
EGAS00001000172
-
Recurrent Somatic Mutations of PTPN1 in Primary Mediastinal B cell lymphoma and Hodgkin Lymphoma
Study
EGAS00001000554
-
Chondromyxoid_fibroma
Study
EGAS00001000533
-
Hypermutation of the inactive X chromosome is a frequent event in cancer
Study
EGAS00001000565
-
RB1 Gene Inactivation by Chromothripsis in Human Retinoblastoma
Study
EGAS00001000598
-
Osteosarcoma_RNAseq
Study
EGAS00001000615
-
Identification_of_drug_resistance_genes_in_melanoma
Study
EGAS00001000617
-
Exploration of CNV’s and SNV’s in cancers with well-known genetic rearrangements: Identification of additional genetic changes in rearrangements-driven cancer
Study
EGAS00001000673
-
WGS of liver cancer in the Japanese population
Study
EGAS00001000678
-
A Comprehensive Catalogue of Somatic Mutations from a Human Cancer Genome
Study
EGAS00000000052
-
Chondrosarcoma_Exome_
Study
EGAS00001000038
-
Kaposi_sarcoma_exome
Study
EGAS00001000032
-
Genome Landscape of Primary Pancreatic Ductal Adenocarcinoma
Study
EGAS00001000154
-
ALK_inhibitors_in_the_context_of_ALK_dependent_cancer_cell_lines
Study
EGAS00001000082
-
Linking genes, genomic instability and molecular subgroups in medulloblastoma
Study
EGAS00001000085
-
UK10K RARE COLOBOMA
Study
EGAS00001000127
-
Splenic_Marginal_Zone_Lymphoma_with_villous_lymphocytes_exome_sequencing
Study
EGAS00001000139
-
Chordoma_Exome_Sequencing
Study
EGAS00001000188
-
Genetic landscape of pediatric Adrenocortical Tumor
Study
EGAS00001000257
-
Genome-wide mutation analysis of germinal-center B-cell derived lymphomas within the ICGC MMML-Seq Consortium
Study
EGAS00001000394
-
Pharmacological and genomic profiling identifies NFκB-targeted treatment strategies for mantle cell lymphoma
Study
EGAS00001000622
-
Whole Exome Sequencing data of six chRCC tumors corresponding to three patients
Study
EGAS00001007104
-
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine
Study
EGAS00001007160